Indo-Rama Synthetics Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indo-Rama Synthetics Tbk. trades at Rp2,030 (market cap 1.33T, 2.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 7.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 2.6K). Which is the better fit depends on your goals.
| INDR | OBAT | |
|---|---|---|
Market Cap | 1.33T | 167.37B |
Volume | 2.6K | 96.7K |
Lot | 26 | 967 |
Turnover | 5.29M | 23.82M |
Average Price | 2,033.08 | 246.34 |
Value | 5.29M | 23.82M |
Indicative Equilibrium Price | 2,030 | 248 |
Indicative Equilibrium Volume | 23 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.
Read more on INDR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →